Myopia is a common cause of correctable vision loss, with uncorrected myopia remaining the leading cause of distance vision impairment globally. Individual studies show variations in the prevalence of myopia and high myopia across regions and ethnic groups. And recent landmark publication estimates that by 2050, half the world population will have myopia.

Clinical studies on atropine for myopia control show mixed results, highlighting the need for more research on dosage and the differing outcomes between children in the U.S. and Asia.